2007
DOI: 10.1016/j.jchromb.2006.07.058
|View full text |Cite
|
Sign up to set email alerts
|

Bioanalysis and pharmacokinetics of chitosan ester in rabbit serum by HPLC with postcolumn fluorescence derivatization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
7
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 15 publications
1
7
0
Order By: Relevance
“…After a single intravenous bolus injection of BR-AEA (0.1 mg/kg), we monitored the drug concentration in plasma for 24 h ( Figure 3). As can be seen for this compound and others, 24 the concentration-time data from rabbit plasma fitted a two-compartment open model. The calculated pharmacokinetic parameters of BR-AEA are listed in Table 2, which shows that BR-AEA has a greater half-life (t 1/2 ) than salbutamol.…”
Section: Pharmacokinetics Study Of Br-aea In Rabbitssupporting
confidence: 64%
See 1 more Smart Citation
“…After a single intravenous bolus injection of BR-AEA (0.1 mg/kg), we monitored the drug concentration in plasma for 24 h ( Figure 3). As can be seen for this compound and others, 24 the concentration-time data from rabbit plasma fitted a two-compartment open model. The calculated pharmacokinetic parameters of BR-AEA are listed in Table 2, which shows that BR-AEA has a greater half-life (t 1/2 ) than salbutamol.…”
Section: Pharmacokinetics Study Of Br-aea In Rabbitssupporting
confidence: 64%
“…The conformational binding site for BR-AEA is in a position that is not favorable for the addition of a sulfate from 3′-phosphoadenosine 5′-phosphosulfate (PAPS) (Figure 5), the last amino acid demonstrated to govern the substrate selectivity of this enzyme. 24 Consequently, these structural differences of BR-AEA at the binding site of all SULTs suggest its low or null metabolism. In similar form, BR-AEA interacted by hydrogen bonds with Tyr240 on SULT1A1 and with Asp60 on SULT1C1.…”
Section: Molecular Modelingmentioning
confidence: 99%
“…The application of bioassay methods, such as enzyme-linked immunosorbent assay (ELISA) techniques, has been limited to pharmaceutical analysis because of the absence of specifi c ligand recognition (Mizuno et al, 2009;Tokita et al, 2010). High performance liquid chromatography (HPLC) methods with post-column fl uorescence derivatization using guanidine as a fl uorometric detection reagent have been developed for the determination of numerous materials, including dermatan sulfate, oversulfated dermatan sulfate, oligomannuronic acid, chitosan and several other carbohydrates (Honda, 1996;Huang et al, 1996;Han et al, 2007;Sun et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…There are several methods available for CTS detection [12][13][14][15]. However, the results were not satisfactory.…”
Section: Introductionmentioning
confidence: 99%